| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.7M | +109.0% |
| SG&A Expense | $27.2M | -38.4% |
| Operating Income | -$78.6M | -6.9% |
| Pre-tax Income | -$71.4M | +3.7% |
| Income Tax | $0 | — |
| Net Income | -$71.4M | +3.7% |
| EPS (Basic) | -$10.70 | +6.1% |
| EPS (Diluted) | -$10.70 | +6.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | -24.6% |
| Current Assets | $191.4M | +53.8% |
| Total Assets | $203.5M | -22.8% |
| Current Liabilities | $4.8M | -38.7% |
| Total Liabilities | $89.7M | -4.8% |
| Stockholders' Equity | $113.9M | -32.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.6M | +34.3% |
| Investing Cash Flow | $25.5M | -52.8% |
| Financing Cash Flow | $7.3M | +315.5% |